THE DEAL, AT A GLANCE
From the announcementTelum Therapeutics
01Who is involvedBacked by ["AMR Action Fund", "Invivo Partners"]From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedTelum Therapeutics raised Series A, announced 2026-07-01From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersTelum Therapeutics’ $18M Series A is a targeted Healthcare & Life Sciences allocation into hospital-acquired infection treatments, led by AMR Action Fund, in a sector…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Telum Therapeutics · Financing Record
Explore source-linked visual explanations for Telum Therapeutics. Unsupported claims are withheld while source review continues.
Record 7117 · Recorded date: 2026-07-01
Explore company records →